Progressive supranuclear palsy: High-field-strength MR microscopy in the human substantia nigra and globus pallidus

Radiology

Volumn 266, Issue 1, 2013, Pages 280-288

  Foroutan, Parastou ^a   Murray, Melissa E ^b   Fujioka, Shinsuke ^b   Schweitzer, Katherine J ^b   Dickson, Dennis W ^b   Wszolek, Zbigniew K ^b   Grant, Samuel C ^a  

^a FAMU FSU COLLEGE OF ENGINEERING   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; FERRIC FERROCYANIDE; FERRITIN; HEMOSIDERIN; IRON;

AGED; ANATOMICAL VARIATION; ARTICLE; AUTOPSY; CEREBRAL PEDUNCLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLOBUS PALLIDUS; HIGH RESOLUTION MAGNETIC RESONANCE MICROSCOPY; HISTOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOREACTIVITY; MALE; MICROGLIA; MICROSCOPY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; STATISTICAL ANALYSIS; SUBSTANTIA NIGRA;

AGED; AGED, 80 AND OVER; CADAVER; FEMALE; GLOBUS PALLIDUS; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBSTANTIA NIGRA; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 84871675300     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.12102273     Document Type: Article

References (38)

1. Seppi K, Poewe W. Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes. Neuroimaging Clin N Am 2010;20(1):29-55.
2. Nath U, Ben-Shlomo Y, Thomson RG, et al. The prevalence of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) in the UK. Brain 2001;124(Pt 7):1438-1449. (Pubitemid 32606104)
3. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47(1):1-9. (Pubitemid 26243849)
4. Stamelou M, de Silva R, Arias-Carrión O, et al. Rational therapeutic approaches to progressive supranuclear palsy. Brain 2010;133(Pt 6):1578-1590.
5. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005;128(Pt 6):1247-1258. (Pubitemid 40826179)
6. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogenous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359.
7. Paviour DC, Price SL, Jahanshahi M, Lees AJ, Fox NC. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations. Mov Disord 2006;21(7):989-996. (Pubitemid 44184601)
8. Fujishiro H, Ferman TJ, Boeve BF, et al. Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol 2008;67(7):649-656.
9. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005;65(12):1863-1872. (Pubitemid 43970103)
10. Murray ME, Knopman DS, Dickson DW. Vascular dementia: clinical, neuroradiologic and neuropathologic aspects. Panminerva Med 2007;49(4):197-207.
11. Josephs KA, Dickson DW. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 2003;18(9):1018-1026. (Pubitemid 37185209)
12. Dickson DW, Rademakers R, Hutton ML. Progressive supranuclear palsy: pathology and genetics. Brain Pathol 2007;17(1):74-82.
13. Ma Y, Hof PR, Grant SC, et al. A three-dimensional digital atlas database of the adult C57BL/6J mouse brain by magnetic resonance microscopy. Neuroscience 2005;135(4):1203-1215. (Pubitemid 41416682)
14. Haines DE. Neuroanatomy: an atlas of structures, sections, and systems. 7th ed. Philadelphia, Pa: Wolters Kluwer/Lippincott Williams & Wilkins, 2008.
15. Bancroft JD, Stevens A. Theory and practice of histological techniques. 4th ed. Edinburgh, NY: Churchill Livingstone, 1996; 245-246.
16. Meadowcroft MD, Connor JR, Smith MB, Yang QX. MRI and histological analysis of beta-amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice. J Magn Reson Imaging 2009;29(5):997-1007.
17. Nabuurs RJ, Hegeman I, Natté R, et al. High-field MRI of single histological slices using an inductively coupled, self-resonant microcoil: application to ex vivo samples of patients with Alzheimer's disease. NMR Biomed 2010 Oct 19. [Epub ahead of print]
18. Meadowcroft MD, Zhang S, Liu W, et al. Direct magnetic resonance imaging of histological tissue samples at 3.0T. Magn Reson Med 2007;57(5):835-841. (Pubitemid 46709403)
19. Quattrone A, Nicoletti G, Messina D, et al. MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy. Radiology 2008;246(1):214-221. (Pubitemid 350305046)
20. Wallis LI, Paley MN, Graham JM, et al. MRI assessment of basal ganglia iron deposition in Parkinson's disease. J Magn Reson Imaging 2008;28(5):1061-1067.
21. Martin WR. Quantitative estimation of regional brain iron with magnetic resonance imaging. Parkinsonism Relat Disord 2009;15(Suppl 3):S215-S218.
22. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3(1):41-51.
23. Martin WR, Ye FQ, Allen PS. Increasing striatal iron content associated with normal aging. Mov Disord 1998;13(2):281-286. (Pubitemid 28127804)
24. Kraft E, Schwarz J, Trenkwalder C, Vogl T, Pfluger T, Oertel WH. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol 1999;56(2):225-228. (Pubitemid 29076187)
25. Rutledge JN, Hilal SK, Silver AJ, Defendini R, Fahn S. Study of movement disorders and brain iron by MR. AJR Am J Roentgenol 1987;149(2):365-379. (Pubitemid 17104998)
26. Youdim MB, Riederer P. The role of iron in senescence of dopaminergic neurons in Parkinson's disease. J Neural Transm Suppl 1993;40:57-67. (Pubitemid 24005557)
27. Götz ME, Double K, Gerlach M, Youdim MB, Riederer P. The relevance of iron in the pathogenesis of Parkinson's disease. Ann N Y Acad Sci 2004;1012:193-208. (Pubitemid 38455479)
28. Wypijewska A, Galazka-Friedman J, Bauminger ER, et al. Iron and reactive oxygen species activity in parkinsonian substantia nigra. Parkinsonism Relat Disord 2010;16(5):329-333.
29. Bartzokis G, Cummings JL, Markham CH, et al. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn Reson Imaging 1999;17(2):213-222. (Pubitemid 29053180)
30. Atasoy HT, Nuyan O, Tunc T, Yorubulut M, Unal AE, Inan LE. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol India 2004;52(3):332-337. (Pubitemid 39430186)
31. Antonini A, Leenders KL, Meier D, Oertel WH, Boesiger P, Anliker M. T2 relaxation time in patients with Parkinson's disease. Neurology 1993;43(4):697-700. (Pubitemid 23121959)
32. Martin WR, Wieler M, Gee M. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 2008;70(16 Pt 2):1411-1417. (Pubitemid 351521933)
33. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 2004;5(11):863-873. (Pubitemid 39482155)
34. Levenson CW, Tassabehji NM. Iron and ageing: an introduction to iron regulatory mechanisms. Ageing Res Rev 2004;3(3):251-263. (Pubitemid 38844695)
35. Gelman BB. Iron in CNS disease. J Neuropathol Exp Neurol 1995;54(4):477-486.
36. Dexter DT, Carayon A, Javoy-Agid F, et al. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 1991;114(Pt 4):1953-1975.
37. Kaneko Y, Kitamoto T, Tateishi J, Yamaguchi K. Ferritin immunohistochemistry as a marker for microglia. Acta Neuropathol (Berl) 1989;79(2):129-136. (Pubitemid 19286137)
38. Ahmed Z, Shaw G, Sharma VP, Yang C, McGowan E, Dickson DW. Actin-binding proteins coronin-1a and IBA-1 are effective microglial markers for immunohistochemistry. J Histochem Cytochem 2007;55(7):687-700. (Pubitemid 46981767)